Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

New strains of MRSA identified in the Gulf region

TAGS: Microbiology
MRSA.jpg
Antibiotic misuse to be a contributory factor to the continuing evolution of MRSA.

MRSA strains are responsible for many difficult-to-treat bacterial infections in humans because they are resistant to several antibiotics. Therefore, infections caused by MRSA are associated with treatment failures resulting in complications, increased length of hospitalisation and, in severe cases, deaths as well as a high economic burden.

The prevalence of MRSA has been rising in recent years and currently, it is estimated that up to 35 per cent of Staphylococcus aureus infections in the UAE are due to MRSA.

A collaborative study with researchers from across the UAE has reported previously unknown MRSA strains in the Gulf region. The study, which was led and funded by Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and published in Scientific Reports, is the first-of-its-kind in the UAE, and a collaboration with teams from Rashid Hospital, Dubai Health Authority, Dubai; Mediclinic City Hospital Dubai; Sheikh Khalifa General Hospital, Umm Al Quwain; and Sheikh Khalifa Medical City, Abu Dhabi; as well as the Leibniz Institute of Photonic Technology and the InfectoGnostics Research Campus in Jena Germany.

To address the lack of data from the UAE, genetic characterisation of MRSA identified between December 2017 and August 2019 was conducted using DNA microarray-based assays. The 625 MRSA isolates studied were grouped into 23 clonal complexes (CCs) and assigned to 103 strains.

Novel MRSA strains

The collaborative efforts produced several key findings, including the existence of an extensive collection of MRSA strains in the UAE and the emergence of MRSA strains not previously identified in the GCC, including rare and novel strains. The study also found that the genetic profile of MRSA indicates antibiotic misuse to be a contributory factor to the continuing evolution of MRSA.

The study also concluded that as some strains detected occur in other countries, a travel connection is possible. Others, which have not been described elsewhere, probably evolved within the region. The lack of documentation of travel history for the patients is a limitation of this study as such information would have been helpful in mapping the travel connections. However, in a population as diverse as the UAE, it should be noted that importation of a strain from abroad could have multiple sources and prior travel by the patient represents only one piece of the puzzle.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
catpromo_webinar
Webinars On Demand

Webinars covering everything from patient safety and diagnostics during COVID-19 to business leadership and healthcare transformation, all available to watch for free on demand. 

Hear from industry leaders like Roche Diagnostics Middle East and Beckman Coulter - or catch up on the wide range of clinical content sessions from the recent Omnia Health Live.

catpromo_webinar